Status:
UNKNOWN
The Novel Approach of Minimally Invasive Parathyroid Surgery Requires Precise Identification and Localization of the Lesion Prior to Exploration
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Hypercalcemia
Hyperparathyroidism
Eligibility:
All Genders
18-75 years
Brief Summary
Purpose of this study is to compare the image quality and diagnostic accuracy obtained with ultrafast solid state short SPECT in comparison with the routine SPECT protocol.
Detailed Description
Single-tracer, dual-phase Tc-MIBI parathyroid scintigraphy is based on the differential washout rate of the tracer (MIBI) from the thyroid and the parathyroid tissue. A distinct focus of increased MIB...
Eligibility Criteria
Inclusion
- 1\) The subject is 18 years old or older. (2) The subject is clinically suspected or known to have parathyroid adenoma and is scheduled to have a MIBI study as part of his/her standard clinical evaluation.
- (3) The subject is able and willing to comply with the additional procedure (ultrafast MIBI SPECT) and a signed and dated informed consent is obtained before any procedure for study purposes is performed.
Exclusion
- Pregnancy.
- Psychosis or any other condition, which, in the investigators opinion would prevent adherence to the study protocol.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01226810
Start Date
January 1 2011
Last Update
October 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Healthcare Campus
Haifa, Israel, 36029